JEL
Mark Identification

JEL

Serial Number

97576363

Filing Date

Sep 2, 2022

Trademark by

AIVIVA BIOPHARMA INC.

Classification Information

Glaucoma agents; Irrigating solutions for eye use; Medicated eye washes; Eye drops; Ocular pharmaceuticals; Ophthalmic preparations; Ophthalmologic preparations; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical products for ophthalmological use; Dermatological pharmaceutical products; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated dermatological preparations and substances; Medicated skin preparation for use in treating wound healing; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Medicated ointments for treating dermatological conditions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin care preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Medicinal creams for skin care; Frostbite salve for pharmaceutical purposes; Poultices; Gelatine for medical purposes; wound-healing ointments for pharmaceutical purposes; Sunburn ointments; Acne treatment preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of gel that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations for prostatic diseases and conditions; Pharmaceutical preparations for benign prostatic hyperplasia; Pharmaceutical preparations for the treatment and prevention of prostatic diseases and conditions; Pharmaceutical preparations for the treatment and prevention of benign prostatic hyperplasia

Pharmaceuticals